17000HCRN-BRE20-468-NCT05467891OpenA Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerBRE20-468NCT05467891InstitutionalAdultTreatmentIINationalOtherKhoury, KatiaGeorgetown University Medical Center : Julie Castle; Lombardi Comprehensive Cancer Center : Julie Castle; Medstar Washington Hospital CenterBreastOncology GroupLombardi Comprehensive Cancer Center (LCCC)- 7263Julie CastleJulie Castle+1 202-687-2209bickmorj@georgetown.eduClinical Research Nurse
2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>